3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
7
Myelodysplastic Syndromes
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Hematologic Neoplasms
5
Lymphoma, Non-Hodgkin
4
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
beta-Thalassemia
2
Lymphoma
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Vasculitis, Central Nervous System
1
Thalassemia
1
Stiff-Person Syndrome
1
Shwachman-Diamond Syndrome
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Rasmussen subacute encephalitis
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Opsoclonus-Myoclonus Syndrome
1
Non-Malignant Neoplasm
1
Neuromyelitis Optica
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Interventions
Nivolumab
70
pembrolizumab
69
cabozantinib
46
Ipilimumab
38
Specimen Handling
33
Magnetic Resonance Spectroscopy
33
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
18
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
thymoglobulin
×
1 year
×
Clear all
No trials found.